Mr. Henry Yau
- Managing Director, HKU Clinical Trials Centre
Henry Yau is managing director of the Hong Kong University (HKU) Clinical Trials Centre in Hong Kong and CEO of the Centre’s mainland China arm. Mr. Yau explains how the clinical trials landscape has evolved in Hong Kong over the past five years, especially in relation to the COVID-19 pandemic. He also covers some hot-button issues in global clinical research and how they pertain to Hong Kong, including cohort diversity, digitalisation, and convergence with medicine regulation and approvals.